Metoclopramide and diphenhydramine in the treatment of hyperemesis gravidarum: Effectiveness and predictors of rehospitalisation
- 31 March 2009
- journal article
- research article
- Published by Elsevier BV in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 143 (1), 43-49
- https://doi.org/10.1016/j.ejogrb.2008.11.007
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Case–Control Study Comparing Droperidol Plus Diphenhydramine with Conventional Treatment in Hyperemesis GravidarumJournal of Pharmacy Technology, 2003
- Comparison of Three Outpatient Regimens in the Management of Nausea and Vomiting in PregnancyJournal of Perinatology, 2003
- Droperidol dropped; consultants not consultedPsychiatric Bulletin, 2003
- RETIRED: The Management of Nausea and Vomiting of PregnancyJournal of Obstetrics and Gynaecology Canada, 2002
- Nausea and vomiting in pregnancy: The problem of perception—is it really a disease?American Journal of Obstetrics and Gynecology, 2002
- Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Droperidol and diphenhydramine in the management of hyperemesis gravidarumAmerican Journal of Obstetrics and Gynecology, 1996
- Hyperemesis gravidarum: epidemiologic features, complications and outcomeEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1995
- New protocol to manage hyperemesis gravidarumJournal of the American Dietetic Association, 1994
- Continuous subcutaneous (SC) infusion of metoclopramide (MCP) using a plastic disposable infusor for the treatment of chemotherapy-induced emesisJournal of Pain and Symptom Management, 1988